<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00848770</url>
  </required_header>
  <id_info>
    <org_study_id>HCPA 07-470</org_study_id>
    <nct_id>NCT00848770</nct_id>
  </id_info>
  <brief_title>Manipulation of Arterial Pressure in Acute Ischemic Stroke</brief_title>
  <acronym>MAPAS</acronym>
  <official_title>Manipulation of Arterial Pressure Early in Non Thrombolysed Acute Ischemic Stroke: Effects on Death and Neurological Disability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a controlled clinical trial among non thrombolysed acute ischemic stroke patients to
      determine the effects of three levels of arterial pressure on death and neurological
      disability. After the admission in the vascular unit of the Emergency Department the patients
      are randomized to maintain during the first 24h the Systolic Arterial Pressure in tree levels
      of pressure: 140 to 160 mmHg; 161 to 180 mmHg and 181 to 200 mmHg. The end point of the study
      is the Modified Rankin score and mortality in three month after the discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To maintain the tree levels of systolic arterial pressure during de first 24h we will use one
      of the two strategies:1) infusion of 500 to 1000ml of saline solution and/or norepinephrine
      solution to increase de systolic pressure or 2) infusion of esmolol or nitroprussiate
      solution to decrease de pressure. Every patient will have a transcranial doppler study in the
      first 24h to measure the mean velocity of cerebral arteries.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ranking score and mortality</measure>
    <time_frame>Three month</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>1, 140 to 160 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Esmolol, NPS or NOR</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2, 161 to 180 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Esmolol, NPS or NOR</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3, 181 to 200 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Esmolol, NPS or NOR</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esmolol, Sodium Nitroprussiate (NPS) or Norepinephrine (NOR)</intervention_name>
    <description>Esmolol(2,5g /10ml + SG5% 240ml = 10mg/ml). Start with a bolus of 500mcg/kg in 1 min (ou 0,5mg/kg)and maintain the dose of 50mcg/kg/min (or 0,05mg/kg/min). Increase de infusion in 25mcg/kg/min after each 5 min until the randomized SAP or if the heart beat is lower than 60. The maximum dose is 200ug/kg/min (ou 0,2 mg/kg/min). If the randomized SAP do not reach the goal pressure with the maximum dose of esmolol, start a infusion of sodium nitroprussiate (NPS).
NPS (50mg + SG5% 250ml= 200mcg/ml). No bolus. Start the infusion with 0,2 mcg/kg/min and maintain 0,5 a 5mcg/kg/min. Increase de dose each 15 min to a maximum of 10mcg/kg/min.
NOR: (8mg/8ml + SG5% 242ml=32mcg/ml)No bolus. Start 1 to 5 mcg/min to a maximum dose of 20mcg/min.</description>
    <arm_group_label>1, 140 to 160 mmHg</arm_group_label>
    <arm_group_label>2, 161 to 180 mmHg</arm_group_label>
    <arm_group_label>3, 181 to 200 mmHg</arm_group_label>
    <other_name>Esmolol, NPS or NOR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esmolol, NPS or NOR</intervention_name>
    <description>We use one of the three drug to manipulate the systolic arterial pressure</description>
    <arm_group_label>1, 140 to 160 mmHg</arm_group_label>
    <arm_group_label>2, 161 to 180 mmHg</arm_group_label>
    <arm_group_label>3, 181 to 200 mmHg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>manipulation of SAP</intervention_name>
    <description>Esmolol or NPS or NOR</description>
    <arm_group_label>1, 140 to 160 mmHg</arm_group_label>
    <arm_group_label>2, 161 to 180 mmHg</arm_group_label>
    <arm_group_label>3, 181 to 200 mmHg</arm_group_label>
    <other_name>Esmolol or NPS or NOR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years or older, with the first Acute Ischemic Stroke within the first 6
             hours of the symptoms and not candidate to thrombolysis

          -  We will also include patients with previous Ischemic Stroke with Ranking score 0 or 1

        Exclusion Criteria:

          -  Improuvment of the symptoms rapidly (in the first 15 min after admission)

          -  Seizures not related do the acute ischemic stroke

          -  Previous ischemic stroke in the last 6 weeks and with Ranking score &gt; 1

          -  Haemorrhagic stroke

          -  Anticoagulation

          -  Hypoglycemia

          -  Shock

          -  Acute heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luiz A Nasi, Physician</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre / UFRGS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luiz A Nasi, Physician</last_name>
    <phone>55 51 9982 18 44</phone>
    <email>lnasi@terra.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miguel Gus</last_name>
    <phone>55 51 81627002</phone>
    <email>mgus@mgus.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre/ UFRGS</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>L A Nasi, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>M Gus, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://clinicaltrials.gov/ct2/show/NCT00848770</url>
    <description>Clinical trial of Manipulation of Arterial Pressure Early in Acute Ischemic Stroke</description>
  </link>
  <results_reference>
    <citation>Potter J, Robinson T, Ford G, James M, Jenkins D, Mistri A, Bulpitt C, Drummond A, Jagger C, Knight J, Markus H, Beevers G, Dewey M, Lees K, Moore A, Paul S; CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. J Hypertens. 2005 Mar;23(3):649-55. Review.</citation>
    <PMID>15716709</PMID>
  </results_reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2009</study_first_submitted>
  <study_first_submitted_qc>February 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2009</study_first_posted>
  <last_update_submitted>December 30, 2009</last_update_submitted>
  <last_update_submitted_qc>December 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2009</last_update_posted>
  <responsible_party>
    <name_title>Hospital de Clinicas de Porto Alegre</name_title>
    <organization>GPPG</organization>
  </responsible_party>
  <keyword>Stroke, Acute</keyword>
  <keyword>Systolic Pressure of Blood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Esmolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

